Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuben Hou

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|February 15, 2014
Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitorsLeiqiang Han, Lei Wang, Xuben Hou, et al.
Bioorganic & Medicinal Chemistry|July 8, 2015
Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitorsLei Wang, Xuben Hou, Huansheng Fu, et al.
Future Medicinal Chemistry|May 14, 2020
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitorsJintong Du, Lulu Liu, Bo Liu, et al.
European Journal of Medicinal Chemistry|May 16, 2021
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitorsTao Liang, Junxin Xue, Zefu Yao, et al.
Bioorganic & Medicinal Chemistry|April 20, 2023
Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitorsYunpeng Zhao, Zefu Yao, Wandi Ren, et al.
Journal of Chemical Information and Modeling|March 11, 2015
Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8Xuben Hou, Jintong Du, Renshuai Liu, et al.
Life Sciences|September 17, 2020
A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-κB pathwayWanzhen Lu, Chan Yang, Xinfeng Xu, et al.
Bioorganic Chemistry|May 10, 2025
Design, synthesis and evaluation of structural optimization derived HDAC6 isoform-selective inhibitorChen Chen, Xiaochun Ma, Yichao Wan, et al.
Bioorganic & Medicinal Chemistry|July 29, 2015
Design, synthesis and biological evaluation of saccharin-based N-hydroxybenzamides as histone deacetylases (HDACs) inhibitorsHuansheng Fu, Leiqiang Han, Xuben Hou, et al.
Journal of Chromatography. A|October 10, 2020
Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral stationary phase with high separation factorYue Yang, Jiangwei Hu, Hao Fang, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|February 15, 2014
Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitorsLeiqiang Han, Lei Wang, Xuben Hou, et al.
Bioorganic & Medicinal Chemistry|July 8, 2015
Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitorsLei Wang, Xuben Hou, Huansheng Fu, et al.
Future Medicinal Chemistry|May 14, 2020
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitorsJintong Du, Lulu Liu, Bo Liu, et al.
European Journal of Medicinal Chemistry|May 16, 2021
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitorsTao Liang, Junxin Xue, Zefu Yao, et al.
Bioorganic & Medicinal Chemistry|April 20, 2023
Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitorsYunpeng Zhao, Zefu Yao, Wandi Ren, et al.
Journal of Chemical Information and Modeling|March 11, 2015
Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8Xuben Hou, Jintong Du, Renshuai Liu, et al.
Life Sciences|September 17, 2020
A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-κB pathwayWanzhen Lu, Chan Yang, Xinfeng Xu, et al.
Bioorganic Chemistry|May 10, 2025
Design, synthesis and evaluation of structural optimization derived HDAC6 isoform-selective inhibitorChen Chen, Xiaochun Ma, Yichao Wan, et al.
Bioorganic & Medicinal Chemistry|July 29, 2015
Design, synthesis and biological evaluation of saccharin-based N-hydroxybenzamides as histone deacetylases (HDACs) inhibitorsHuansheng Fu, Leiqiang Han, Xuben Hou, et al.
Journal of Chromatography. A|October 10, 2020
Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral stationary phase with high separation factorYue Yang, Jiangwei Hu, Hao Fang, et al.
Pageof 9